{"id":"insulin-titration","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Injection site reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin titration involves systematically increasing or decreasing insulin doses in response to measured blood glucose concentrations and patient metabolic needs. This approach aims to maintain target glucose ranges while minimizing hypoglycemia risk. It is a clinical management protocol rather than a novel drug entity.","oneSentence":"Insulin titration is a dosing strategy that adjusts insulin administration based on blood glucose levels to achieve optimal glycemic control.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:49:18.755Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus requiring insulin therapy"}]},"trialDetails":[{"nctId":"NCT07361874","phase":"NA","title":"IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-03-05","conditions":"Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS), Subclinical Cushing's","enrollment":75},{"nctId":"NCT04542148","phase":"PHASE2","title":"Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2022-02-10","conditions":"Diabetes Mellitus, Type 2, Preterm Birth, Pregnancy, High Risk","enrollment":120},{"nctId":"NCT06671587","phase":"PHASE4","title":"iGlarLixi CGM Study in Chinese T2D Individuals After OADs","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-12-10","conditions":"Type 2 Diabetes (T2D)","enrollment":678},{"nctId":"NCT06111508","phase":"NA","title":"The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2023-11-29","conditions":"Type 2 Diabetes","enrollment":30},{"nctId":"NCT00743782","phase":"PHASE2","title":"Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2008-08-22","conditions":"Hypoparathyroidism, Hypocalcemia, Autoimmune Polyendocrine Syndrome Type 1","enrollment":21},{"nctId":"NCT02616666","phase":"PHASE4","title":"A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2016-08-25","conditions":"Type 2 Diabetes Mellitus","enrollment":632},{"nctId":"NCT06024928","phase":"NA","title":"Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2024-06-18","conditions":"Type 2 Diabetes","enrollment":23},{"nctId":"NCT01239550","phase":"NA","title":"Insulin Detemir in Obesity Management","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","startDate":"2011-04","conditions":"Diabetes, Obesity","enrollment":240},{"nctId":"NCT05724134","phase":"PHASE1","title":"Pancreatic Clamp in NAFLD","status":"COMPLETED","sponsor":"Columbia University","startDate":"2023-08-29","conditions":"Insulin Resistance, Prediabetic State, Hyperinsulinemia","enrollment":18},{"nctId":"NCT05000021","phase":"NA","title":"Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes","status":"RECRUITING","sponsor":"Albert Einstein College of Medicine","startDate":"2022-06-27","conditions":"Type 1 Diabetes","enrollment":93},{"nctId":"NCT07291804","phase":"NA","title":"Efficacy and Safety of an Intelligent Insulin-Dosing Decision Support System for Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Study","status":"COMPLETED","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2025-03-01","conditions":"Diabetes Mellitus，Type 2","enrollment":140},{"nctId":"NCT00803179","phase":"PHASE1","title":"Growth Hormone Therapy for Wasting in Cystic Fibrosis","status":"TERMINATED","sponsor":"University of Massachusetts, Worcester","startDate":"2008-11","conditions":"Cystic Fibrosis","enrollment":5},{"nctId":"NCT05823948","phase":"PHASE3","title":"A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2023-04-11","conditions":"Diabetes Mellitus, Type 2","enrollment":51},{"nctId":"NCT04029480","phase":"PHASE3","title":"Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-10-08","conditions":"Type 2 Diabetes Mellitus","enrollment":166},{"nctId":"NCT05734313","phase":"NA","title":"Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression","status":"RECRUITING","sponsor":"Albert Einstein College of Medicine","startDate":"2023-03-31","conditions":"Diabetes, Type 1 Diabetes","enrollment":94},{"nctId":"NCT07194642","phase":"NA","title":"Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Non-ICU Patients Receiving Corticosteroid Therapy and Specialized Nutrition","status":"NOT_YET_RECRUITING","sponsor":"University of Nebraska","startDate":"2025-09-30","conditions":"Diabetes","enrollment":80},{"nctId":"NCT05002933","phase":"PHASE4","title":"A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension Period","status":"COMPLETED","sponsor":"Sanofi","startDate":"2021-05-20","conditions":"Type 2 Diabetes Mellitus","enrollment":570},{"nctId":"NCT04980027","phase":"PHASE4","title":"Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs","status":"COMPLETED","sponsor":"Sanofi","startDate":"2021-06-07","conditions":"Type 2 Diabetes Mellitus","enrollment":228},{"nctId":"NCT06529705","phase":"NA","title":"Performance and Safety Evaluation of the EkiYou V2 Application in Patients With Diabetes Using Multiple Daily Insulin Injections (EkiYou-Study1)","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2024-08-19","conditions":"Diabetes Type 1, Diabetes Type 2 on Insulin, Pancreatogenous Diabetes","enrollment":21},{"nctId":"NCT04760626","phase":"PHASE3","title":"A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-03-01","conditions":"Diabetes Mellitus, Type 2","enrollment":1085},{"nctId":"NCT07109245","phase":"PHASE4","title":"Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?","status":"NOT_YET_RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2025-09-01","conditions":"Brain Insulin Sensitivity, Healthy Controls, Cognition","enrollment":35},{"nctId":"NCT05662332","phase":"PHASE3","title":"A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2023-01-14","conditions":"Type 2 Diabetes, T2D","enrollment":795},{"nctId":"NCT06605859","phase":"","title":"DigiDiab Pilot Spain - Nursing Home and Domiciliary Nursing Care","status":"RECRUITING","sponsor":"Medical University of Graz","startDate":"2025-04-08","conditions":"Type 2 Diabetes","enrollment":40},{"nctId":"NCT06616779","phase":"","title":"DigiDiab Evaluation Domiciliary Nursing Care","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2024-11-30","conditions":"Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, Insulin Requiring","enrollment":40},{"nctId":"NCT02879409","phase":"NA","title":"HbA1c Variability in Type II Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Cornell Medical College in Qatar","startDate":"2016-11","conditions":"Diabetes Mellitus Type 2","enrollment":150},{"nctId":"NCT05922033","phase":"PHASE4","title":"Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2023-10-19","conditions":"Gestational Diabetes Mellitus, Pregnancy in Diabetic, Pregnancy, High Risk","enrollment":56},{"nctId":"NCT06738849","phase":"NA","title":"EkiYou-Study-2 : A National Multicentric Trial of the EkiYou Application for Insulin Bolus Calculation","status":"RECRUITING","sponsor":"DiappyMed","startDate":"2024-11-05","conditions":"Diabetes Type 1, Diabetes Type 2 on Insulin, Pancreatogenous Diabetes","enrollment":154},{"nctId":"NCT06411210","phase":"PHASE2","title":"Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-07-16","conditions":"Diabetes type1, Obesity","enrollment":54},{"nctId":"NCT05702073","phase":"PHASE3","title":"To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin.","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2023-03-31","conditions":"Type 2 Diabetes Mellitus","enrollment":423},{"nctId":"NCT06850129","phase":"NA","title":"Efficacy of a Digital Educational Intervention in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"HOSPITAL VITHAS SEVILLA","startDate":"2020-10-26","conditions":"Diabetes Mellitus Type 2","enrollment":85},{"nctId":"NCT05699408","phase":"PHASE3","title":"To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With Oral Antidiabetic Drugs","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2023-03-31","conditions":"Type 2 Diabetes","enrollment":513},{"nctId":"NCT06807827","phase":"NA","title":"Pharmacist-Led Cognitive Behavioral Intervention for Diabetic Patients: a Randomized Interventional Trial to Evaluate the Impact on Medication Adherence and Quality of Life","status":"NOT_YET_RECRUITING","sponsor":"Hamdard University","startDate":"2025-02-20","conditions":"Diabete Mellitus","enrollment":385},{"nctId":"NCT03087032","phase":"PHASE4","title":"Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2019-01-10","conditions":"Type 2 Diabetes Patients, Overweight and Obesity, Hyperglycaemia (Diabetic)","enrollment":164},{"nctId":"NCT04784637","phase":"NA","title":"Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2021-07-23","conditions":"Type 1 Diabetes Mellitus","enrollment":31},{"nctId":"NCT01420302","phase":"NA","title":"LOGIC-Insulin Algorithm-guided Versus Nurse-directed Blood Glucose Control During Critical Illness","status":"COMPLETED","sponsor":"Greet Van den Berghe","startDate":"2011-08","conditions":"Critical Illness","enrollment":300},{"nctId":"NCT05441631","phase":"PHASE1","title":"Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients","status":"COMPLETED","sponsor":"Benha University","startDate":"2020-04-01","conditions":"COVID-19, Dysglycemia","enrollment":436},{"nctId":"NCT02403284","phase":"PHASE4","title":"The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans","status":"COMPLETED","sponsor":"Phoenix VA Health Care System","startDate":"2013-03","conditions":"Insulin Resistance","enrollment":97},{"nctId":"NCT05684341","phase":"NA","title":"A Randomized Controlled Trial to Compare the Glycemic Control, With or Without the Connected Solution, of Adult Type 2 Diabetic Participants on Basal Insulin in Taiwan","status":"COMPLETED","sponsor":"Sanofi","startDate":"2023-02-17","conditions":"Type 2 Diabetes Mellitus","enrollment":200},{"nctId":"NCT06126354","phase":"PHASE1","title":"Dexamethasone/Pancreatic Clamp P&F","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2024-07-01","conditions":"Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease","enrollment":""},{"nctId":"NCT03380546","phase":"PHASE3","title":"Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-07-04","conditions":"Gestational Diabetes Mellitus in Pregnancy","enrollment":341},{"nctId":"NCT03324776","phase":"PHASE3","title":"Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Model Clinical Research LLC","startDate":"2017-10-16","conditions":"Type2 Diabetes","enrollment":20},{"nctId":"NCT04642378","phase":"NA","title":"Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus Patients","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-10-01","conditions":"Type 2 Diabetes","enrollment":149},{"nctId":"NCT02953665","phase":"PHASE2","title":"Safety and Efficacy of Liraglutide in Parkinson's Disease","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2017-04-03","conditions":"Parkinson Disease","enrollment":63},{"nctId":"NCT03455985","phase":"NA","title":"Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin","status":"TERMINATED","sponsor":"Ohio State University","startDate":"2018-05-01","conditions":"Diabetes Mellitus, Type 2, Patient Discharge, Blood Glucose, Low","enrollment":158},{"nctId":"NCT04678661","phase":"NA","title":"My Dose Coach Mobile App to Support Insulin Titration and Maintenance","status":"TERMINATED","sponsor":"Linda Siminerio","startDate":"2021-02-15","conditions":"Diabetes Mellitus Type 2 - Insulin-Treated","enrollment":60},{"nctId":"NCT01970345","phase":"PHASE2","title":"A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-05","conditions":"Autism Spectrum Disorder","enrollment":3},{"nctId":"NCT00455858","phase":"PHASE4","title":"Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":87},{"nctId":"NCT05029271","phase":"NA","title":"InPen User Experience","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2023-04-17","conditions":"Diabetes Type 1","enrollment":34},{"nctId":"NCT05081011","phase":"NA","title":"Managing Insulin With a Voice AI","status":"COMPLETED","sponsor":"Stanford University","startDate":"2021-03-24","conditions":"Medication Adherence","enrollment":39},{"nctId":"NCT00101751","phase":"PHASE4","title":"INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-10","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":4877},{"nctId":"NCT03737240","phase":"PHASE3","title":"IDegLira HIGH Trial","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-01-15","conditions":"Diabetes Mellitus","enrollment":145},{"nctId":"NCT03704103","phase":"NA","title":"mHealth Insulin Titration and Management (iSage)","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2018-08-28","conditions":"Type 2 Diabetes Mellitus","enrollment":6},{"nctId":"NCT05409391","phase":"NA","title":"Insulin Titration System Based on Deep Learning","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2022-06-15","conditions":"Diabetes Mellitus Type 2 - Insulin-Treated","enrollment":16},{"nctId":"NCT03665207","phase":"PHASE3","title":"Tight Versus Liberal Blood Glucose Control in Adult Critically Ill Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"KU Leuven","startDate":"2018-09-18","conditions":"Critical Illness, Hyperglycemia","enrollment":9230},{"nctId":"NCT03029390","phase":"PHASE4","title":"Effect of Berberine Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes","status":"UNKNOWN","sponsor":"University of Guadalajara","startDate":"2016-03","conditions":"Prediabetes, Impaired Fasting Glucose, Impaired Glucose Tolerance","enrollment":28},{"nctId":"NCT02621489","phase":"PHASE4","title":"Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2015-12","conditions":"Atherosclerosis, Diabetes, Restenosis","enrollment":38},{"nctId":"NCT04663282","phase":"PHASE2","title":"A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2021-02-04","conditions":"Type 2 Diabetes","enrollment":179},{"nctId":"NCT05591391","phase":"NA","title":"The Efficacy of Mallya in Type 2 Diabetes Transiting From Oral Antidiabetic Drugs to iGlarLixi","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2022-09-28","conditions":"Mallya","enrollment":40},{"nctId":"NCT05098301","phase":"","title":"Data Therapy Collection to Evaluate Performances of an Automated Insulin Titration Algorithm Compared to Standard Method of Titration","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2021-11-30","conditions":"Diabetes","enrollment":30},{"nctId":"NCT01565941","phase":"PHASE3","title":"Heart And Lung Failure - Pediatric INsulin Titration Trial","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2012-04","conditions":"Heart Failure, Respiratory Failure","enrollment":713},{"nctId":"NCT04585776","phase":"PHASE2","title":"A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2020-10-30","conditions":"Type 1 Diabetes","enrollment":31},{"nctId":"NCT05372471","phase":"NA","title":"Efficacy of the Digital Platform for Diabetes Care Compared to Usual Care in Patients Diagnosed With Type 2 Diabetes.","status":"COMPLETED","sponsor":"Hospital Universitario San Ignacio","startDate":"2020-10-01","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":84},{"nctId":"NCT02545842","phase":"PHASE4","title":"Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-09-07","conditions":"Type 2 Diabetes Mellitus","enrollment":947},{"nctId":"NCT03767543","phase":"PHASE3","title":"Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-03-11","conditions":"Type 2 Diabetes Mellitus","enrollment":265},{"nctId":"NCT03406000","phase":"PHASE4","title":"Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-01-22","conditions":"Type I Diabetes Mellitus","enrollment":170},{"nctId":"NCT05331469","phase":"PHASE4","title":"Difference of Basal Insulin Titration Method in Reducing HbA1c Among Type 2 Diabetes Mellitus (T2DM) Patients.","status":"UNKNOWN","sponsor":"University of Malaya","startDate":"2021-07-19","conditions":"to Identify Which Titration Regimen of Basal Insulin (Being Daily Titration vs 3 Daily Titration) is Better in Reducing hba1c and Have Lesser Hypoglycemia","enrollment":70},{"nctId":"NCT03260868","phase":"PHASE4","title":"Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)","status":"TERMINATED","sponsor":"Sanofi","startDate":"2017-09-19","conditions":"Type 1 Diabetes Mellitus","enrollment":15},{"nctId":"NCT02735044","phase":"PHASE3","title":"Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-04-14","conditions":"Type 1 Diabetes Mellitus","enrollment":463},{"nctId":"NCT01499082","phase":"PHASE3","title":"Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2011-12","conditions":"Type 2 Diabetes Mellitus","enrollment":807},{"nctId":"NCT01499095","phase":"PHASE3","title":"Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy","status":"COMPLETED","sponsor":"Sanofi","startDate":"2011-12","conditions":"Type 2 Diabetes Mellitus","enrollment":811},{"nctId":"NCT02227862","phase":"PHASE3","title":"Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)","status":"COMPLETED","sponsor":"Mylan Inc.","startDate":"2014-06","conditions":"Type 1 Diabetes","enrollment":558},{"nctId":"NCT02410343","phase":"PHASE3","title":"Study of TV-1106 in Growth Hormone-Deficient Adults","status":"TERMINATED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2015-04-30","conditions":"Growth Hormone Deficiency","enrollment":14},{"nctId":"NCT01811576","phase":"PHASE2","title":"Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-03-31","conditions":"Growth Hormone Deficiency","enrollment":52},{"nctId":"NCT03670641","phase":"PHASE4","title":"Remission Through Early Monitored Insulin Therapy - Duration Month","status":"COMPLETED","sponsor":"Sandra Sobel","startDate":"2019-03-26","conditions":"Type 2 Diabetes Mellitus","enrollment":10},{"nctId":"NCT04864977","phase":"PHASE4","title":"A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes","status":"WITHDRAWN","sponsor":"Eli Lilly and Company","startDate":"2021-08-16","conditions":"Type 2 Diabetes, Type 2 Diabetes Treated With Insulin","enrollment":""},{"nctId":"NCT03389490","phase":"PHASE4","title":"Toujeo Versus NPH Self-titration Study","status":"COMPLETED","sponsor":"Elaine Chow","startDate":"2018-01-01","conditions":"Diabetes Mellitus, Type 2","enrollment":50},{"nctId":"NCT03338010","phase":"PHASE3","title":"A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2018-03-22","conditions":"Type 2 Diabetes","enrollment":536},{"nctId":"NCT02597101","phase":"PHASE2","title":"Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes","status":"COMPLETED","sponsor":"Nick Giannoukakis, PhD","startDate":"2015-11","conditions":"Type 2 Diabetes Mellitus, Insulin Resistance","enrollment":14},{"nctId":"NCT02527265","phase":"PHASE2","title":"Afrezza Safety and Pharmacokinetics Study in Pediatric Patients","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2017-09-28","conditions":"Type 1 Diabetes Mellitus","enrollment":30},{"nctId":"NCT03751657","phase":"PHASE2","title":"A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2018-11-29","conditions":"Diabetes Mellitus, Type 2","enrollment":247},{"nctId":"NCT04517201","phase":"NA","title":"AI-Assisted Insulin Titration System on Inpatients Glucose Control","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2020-11-04","conditions":"Type 2 Diabetes","enrollment":120},{"nctId":"NCT03736785","phase":"PHASE2","title":"A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2018-11-15","conditions":"Type 2 Diabetes Mellitus","enrollment":399},{"nctId":"NCT03819790","phase":"PHASE4","title":"The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians","status":"COMPLETED","sponsor":"LMC Diabetes & Endocrinology Ltd.","startDate":"2018-10-02","conditions":"Diabetes Mellitus, Type 2","enrollment":119},{"nctId":"NCT01654120","phase":"PHASE4","title":"Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics","status":"COMPLETED","sponsor":"Mountain Diabetes and Endocrine Center","startDate":"2011-12","conditions":"Diabetes Mellitus, Type II","enrollment":37},{"nctId":"NCT04736225","phase":"NA","title":"Effects of the Insulin Self Titration Education for Type 2 Diabetes Mellitus Patients","status":"COMPLETED","sponsor":"National Taipei University of Nursing and Health Sciences","startDate":"2010-06-01","conditions":"Type2 Diabetes","enrollment":120},{"nctId":"NCT00593489","phase":"NA","title":"Advancing Insulin Prescribing in General Practice","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2006-07","conditions":"Diabetes Mellitus","enrollment":154},{"nctId":"NCT02229227","phase":"PHASE3","title":"Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-11-21","conditions":"Diabetes Mellitus, Type 2","enrollment":814},{"nctId":"NCT03406663","phase":"NA","title":"The Korean TITRATION Study: Comparison of the Self-titration Methods for Glargine-300","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2017-10-01","conditions":"Type 2 Diabetes Mellitus","enrollment":130},{"nctId":"NCT04196231","phase":"PHASE4","title":"Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2019-11-27","conditions":"Type 2 Diabetes","enrollment":258},{"nctId":"NCT02179788","phase":"PHASE1, PHASE2","title":"Metformin to Augment Low Milk Supply (MALMS) Study","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2014-06","conditions":"Low Milk Supply, Pre-diabetes, Insulin Resistance","enrollment":15},{"nctId":"NCT04553380","phase":"NA","title":"Study on the Feasibility of Community Doctors Guided by Specialists to Use Basic Insulin","status":"UNKNOWN","sponsor":"Shenzhen Second People's Hospital","startDate":"2020-12-01","conditions":"Type 2 Diabetes","enrollment":150},{"nctId":"NCT01892969","phase":"","title":"Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2012-10","conditions":"Heart Failure, Respiratory Failure","enrollment":304},{"nctId":"NCT04053959","phase":"PHASE4","title":"Artificial Intelligence Assisted Insulin Titration System","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2019-09-27","conditions":"Type 2 Diabetes","enrollment":46},{"nctId":"NCT03311516","phase":"NA","title":"New Insulin Therapy by Multiwave Bolus","status":"UNKNOWN","sponsor":"Central Hospital, Nancy, France","startDate":"2019-10-10","conditions":"Type1diabetes","enrollment":150},{"nctId":"NCT03881995","phase":"PHASE4","title":"Effects of Insulin Glargine and Lixisenatide on the Brain","status":"TERMINATED","sponsor":"University Hospital Tuebingen","startDate":"2019-03-18","conditions":"Diabetes Mellitus, Type 2","enrollment":1},{"nctId":"NCT02320721","phase":"PHASE3","title":"Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-01","conditions":"Type 2 Diabetes Mellitus","enrollment":1014},{"nctId":"NCT01854723","phase":"PHASE4","title":"Comparison Study of Insulin Glargine and NPH Insulin","status":"WITHDRAWN","sponsor":"Providence Health & Services","startDate":"2013-04","conditions":"Diabetes","enrollment":""},{"nctId":"NCT02690883","phase":"PHASE4","title":"Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2016-04-08","conditions":"Diabetic Nephropathies","enrollment":92},{"nctId":"NCT03091712","phase":"NA","title":"Insulin Degludec Titration Using Mobile Insulin Dosing System","status":"COMPLETED","sponsor":"Glooko","startDate":"2017-05-05","conditions":"Type 2 Diabetes Mellitus","enrollment":240},{"nctId":"NCT03365180","phase":"PHASE2, PHASE3","title":"Starter Kit Study in Insulin naïve Patients","status":"COMPLETED","sponsor":"Signe Schmidt","startDate":"2018-01-03","conditions":"Diabetes Mellitus, Type 2","enrollment":8}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":260,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lantus, Levemir, Novolog, Lispro"],"phase":"marketed","status":"active","brandName":"Insulin Titration","genericName":"Insulin Titration","companyName":"Weill Medical College of Cornell University","companyId":"weill-medical-college-of-cornell-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin titration is a dosing strategy that adjusts insulin administration based on blood glucose levels to achieve optimal glycemic control. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus requiring insulin therapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}